The Bangkok Dusit Medical Services Public Company Limited (BDMS) recently announced a partnership with AstraZeneca (Thailand) Co Ltd. The partnership aims to leverage Artificial Intelligence (AI) in the fight against lung cancer, with the potential to significantly reduce mortality rates. The collaboration will initially be piloted at the Bangkok Cancer Hospital Wattanosoth, following the signing of a Memorandum of Understanding (MoU) between the two parties.
Cancer is currently the leading cause of death in 48 countries worldwide, including Thailand, as reported by Thiravud Khuhaprema, director of the Bangkok Cancer Hospital Wattanosoth. The nation records 190,000 cancer cases annually, with a devastating mortality rate of 120,000 deaths each year. This translates to 14 people succumbing to the disease every single hour.
Lung cancer is the deadliest form…
